Society for Inherited Metabolic Disorders Annual Meeting

遗传性代谢紊乱学会年会

• 批准号: 10623320
• 负责人: Gerard Thomas Berry
• 金额: $ 1万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-06-01 至 2027-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10623320
• 关键词: Affect; American; Area; Arthritis; Award; Biochemistry; Blindness; Cerebral Palsy; Cities; Clinical; Clinical Trials; Congresses; Country; Development; Diabetes Mellitus; Disease; Enzymes; Failure; Funding; Genes; Genetic; Goals; Grant; Growth; Heart Diseases; Hepatic; Inborn Errors of Metabolism; Individual; Inherited; Intellectual functioning disability; International; Japan; Knowledge; Mass Spectrum Analysis; Medical Genetics; Metabolic; Metabolic Diseases; Minority; Molecular; Neonatal Screening; Neuromuscular Diseases; Pathway interactions; Patient Care; Pharmaceutical Preparations; Physicians; Privatization; Recruitment Activity; Research; Research Personnel; Scholarship; Societies; Sodium Chloride; Source; Specialist; Training; Travel; United States National Institutes of Health; Variant; Woman; cost; design; effective therapy; efficacy evaluation; exome; genome sequencing; kidney dysfunction; medical schools; meetings; novel therapeutics; screening program; whole genome

ABSTRACT The Society for Inherited Metabolic Disorders (SIMD) requests support to provide scholarships for trainees to attend its annual meetings in years 2023 to 2027. The 2022 meeting will be held in Orlando, FL April 10-13, 2022. The 2022 meeting will be supported by no-cost extension of the previous grant. The 2023 meeting will be held in Salt Lake City, UT March 18-21, 2023 in conjunction with the American College of Medical Genetics (ACMG) following their meeting. The 2024 meeting is TBD. The 2025 meeting will be held in conjunction with the International Congress on Inborn Errors of Metabolism in Kyoto, Japan. The 2026 meeting is TBD. The 2027 meeting is TBD. Inborn errors of metabolism (IEM) are an important cause of intellectual disability, cerebral palsy, neuromuscular disease, cardiac disorders, hepatic and renal dysfunction, arthritis, diabetes, growth failure and blindness. As the wide clinical and molecular spectrum of these disorders is being elucidated, in part fueled by the development of tandem mass spectroscopy and the rapid expansion of newborn screening programs, the number of affected individuals is now known to be much larger than originally recognized. In addition, therapies are available for some conditions, but few clinical trials have been performed to evaluate their efficacy. Thus, much remains to be done to better understand these severe disorders and develop effective treatments for them. For the U.S. to remain pre-eminent in this important area of research, it is essential to attract young investigators into the field. One effective mechanism to achieve this goal is to provide them with the opportunity to participate in the SIMD meeting, where they can explore the field and develop scientific ties to other established investigators. The SIMD meeting is held annually and participation, especially by young investigators, has been steadily increasing each year. The availability of NIH travel awards has been a major reason for this increase. Trainees seeking funding are required to submit an abstract describing original research to be presented at the meeting. We anticipate submission of 40 abstracts for presentation at each meeting from trainees/young investigators with twice that number for the international meeting (2025). Applications for travel awards will be competitively reviewed 4 months prior to each meeting, with the goal of making up 10 annual awards of $1,000 each for the national meeting and up to 5 awards of $2,000 for the International meeting. Additional funds will be solicited from private sources. Women and minority applicants will be actively recruited.

抽象的 遗传性代谢紊乱协会 (SIMD) 请求支持为学员提供奖学金 参加 2023 年至 2027 年的年会。2022 年会议将于 4 月 10 日至 13 日在佛罗里达州奥兰多举行， 2022 年。2022 年会议将得到先前赠款免费延期的支持。 2023 年会议将于 与美国医学遗传学学院联合举办，于 2023 年 3 月 18 日至 21 日在犹他州盐湖城举行 （ACMG）会议结束后。 2024 年会议时间待定。 2025 年会议将与 在日本京都举行的国际先天性代谢缺陷大会。 2026 年会议召开时间待定。 2027年 会议时间待定。 先天性代谢缺陷（IEM）是导致智力障碍、脑瘫、神经肌肉疾病的重要原因 疾病、心脏病、肝肾功能障碍、关节炎、糖尿病、生长障碍和失明。作为 这些疾病的广泛临床和分子谱正在被阐明，部分是由发展推动的 串联质谱法和新生儿筛查计划的迅速扩大，受影响的人数 现在已知个体比最初认识的要大得多。此外，治疗方法还可用于 某些情况下，但很少进行临床试验来评估其疗效。因此，还有很多工作要做 为了更好地了解这些严重疾病并开发有效的治疗方法。对于美国来说 为了在这一重要的研究领域保持领先地位，吸引年轻研究人员进入该领域至关重要。 实现这一目标的一个有效机制是为他们提供参与 SIMD 的机会 会议，他们可以探索该领域并与其他知名研究人员建立科学联系。单指令多数据流 会议每年举行一次，参与人数，特别是年轻研究者的参与人数，每年都在稳步增加 年。 NIH 旅行奖励的提供是这一增长的主要原因。寻求资金的学员 需要提交一份描述要在会议上展示的原创研究的摘要。我们预计 受训者/年轻研究者提交 40 份摘要供每次会议上展示，其中摘要数量是该摘要的两倍 国际会议编号（2025 年）。旅行奖励申请将接受竞争性审查 4 每次会议前几个月，目标是为全国范围内颁发 10 份年度奖金，每份奖金 1,000 美元 会议，并为国际会议颁发最多 5 个 2,000 美元的奖项。额外资金将向私人募集 来源。将积极招募女性和少数族裔申请人。